Top advisers to the Centers for Disease Control and Prevention are asking the agency’s acting director to explain the abrupt removal of information and data from CDC websites, and say when it ...

No reason was provided for the discontinuation. Zinplava ™ (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the Food and Drug Administration’s (FDA) drug shortages ...

An international study of cancer patients with Clostridioides difficile infection (CDI) found recurrence rates were significant ... The US Centers for Disease Control and Prevention (CDC) today ...

FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong ... To learn more about REBYOTA, in-home administration, and other information, please visit ...

This special series of commentaries, interviews, and slideshows is part of a collaboration between CDC and Medscape. This content is designed to deliver CDC's authoritative guidance directly to ...

A page with information on food safety for pregnant people was also removed. One government staffer told NBC News that CDC officials struggled with implementing the policy and “began pulling ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...